Subscribe
77
Wang Xiang Yu
Pulmonology
About me
Loudi Central Hospital, Department of Respiratory Medicine, attending physician, has been engaged in clinical work in respiratory medicine for many years, and has rich clinical experience in the diagnosis and treatment of respiratory system diseases.
Proficient in diseases
Specializes in common respiratory diseases such as upper respiratory tract infections, pneumonia, chronic bronchitis, emphysema, and tuberculosis.
Voices
How to test for tuberculosis
To examine pulmonary tuberculosis, it is essential to understand that it pertains to tuberculosis changes in the lung tissue, airways, bronchi, and pleura. The pathogen causing tuberculosis is Mycobacterium tuberculosis, also known as the tubercle bacillus. There are multiple tests available for people with pulmonary tuberculosis, as the disease can vary based on location and type. Therefore, such patients generally require numerous tests. The most commonly used are imaging studies for the chest, including X-rays and CT scans. In imaging studies, most patients will show some lesions, but there are instances where tuberculosis in the airways and bronchi might not be clearly visible on CT or X-rays, necessitating more invasive tests like bronchoscopy. Additionally, bacteriological examinations, such as sputum smear and pleural fluid smear, as well as culture for Mycobacterium tuberculosis, are typically conducted for patients. Nowadays, hospitals equipped with the necessary facilities conduct molecular biological tests, namely nucleic acid testing for Mycobacterium tuberculosis DNA. Furthermore, some patients with complex conditions may require a histopathological biopsy, commonly referred to as tissue sampling, at the site of the lesion to observe under a microscope for characteristic changes indicative of tuberculosis. There are also immunological tests that assist in diagnosing tuberculosis, such as the gamma interferon release assay (commonly known as the T-SPOT), tuberculin skin test, and traditional antibody tests against Mycobacterium tuberculosis.
How is tuberculosis treated?
The primary treatment for tuberculosis is still chemotherapy, also simply called chemo, but the chemotherapy for tuberculosis is completely different from the anti-tumor chemotherapy we talk about in cancer, and the medications are also completely different. There are about more than ten anti-tuberculosis drugs, which can be divided into first-line and second-line drugs, and currently, there are third-line drugs under research. Chemotherapy for patients with pulmonary tuberculosis should be started early and administered in combination. The types of combined medication for patients with pulmonary tuberculosis generally involve three or more drugs. Some patients may exhibit drug resistance or intolerance to some drugs' side effects, and thus, second-line drugs may be used. Additionally, some patients, due to special conditions, may require four or five types of anti-tuberculosis drugs. It is crucial to strictly follow medical advice regarding how to medicate and treat. Furthermore, patients with pulmonary tuberculosis must ensure complete medication adherence, as the treatment duration for tuberculosis is quite long, typically requiring at least six months, and some patients may need one or even two years. Regular medication intake is very important because some patients might experience symptoms like coughing up blood or others, such as those with pleurisy, who might develop pleural effusion. Therefore, treatments targeted at other symptoms are necessary. Patients who cough up blood might need hemostatic drugs, while those with severe hemoptysis may even require interventional surgery. Some with tuberculous pleurisy might need to have pleural effusion drained. Additionally, some patients with pulmonary tuberculosis might experience adverse reactions to medications, such as liver or kidney failure, visual impairment, or numbness in the hands, which would require adjustments to their medication or changes based on their complications. Treatment should also be targeted toward these adverse reactions.
Is pertussis a Class B infectious disease?
Pertussis, or whooping cough, is definitely classified as a contagious disease. According to the current infectious disease management laws in our country, pertussis is categorized under Class B infectious diseases. After understanding that it is a Class B infectious disease, we should also be aware of how infectious diseases are classified in our country. They are divided into Class A, Class B, and Class C based on the level of harm caused by the disease. Simply put, the more harmful, the less effective the treatment, and the higher the mortality rate, the more likely the disease will be classified as Class A, such as plague and cholera. On the other hand, diseases that are less harmful, such as influenza, rubella, and leprosy, are classified under Class C.
Can people with tuberculosis drink alcohol?
Whether patients with tuberculosis can drink alcohol, first of all, it is important to know that tuberculosis is a chronic infectious disease and a consumptive disease that consumes the body's calories. Drinking alcohol can affect the body's absorption of energy. Moreover, most patients with tuberculosis need to take anti-tuberculosis medication, most of which are metabolized through the liver and can cause varying degrees of liver damage. Drinking alcohol can exacerbate liver damage and reduce the effectiveness of the medication. Additionally, since there are many types of anti-tuberculosis medications for tuberculosis patients, some medications may cause adverse reactions when drinking alcohol. Therefore, all tuberculosis patients must strictly abstain from drinking alcohol during treatment.
Can tuberculosis be cured completely?
Whether tuberculosis can be completely cured varies from person to person. Most cases of tuberculosis, especially initial occurrences of pulmonary tuberculosis, can be cured in more than 80 to 90 percent of patients if they undergo standardized anti-tuberculosis treatment. However, it is essential that the treatment is standardized; it is not appropriate to simply take medication for one or two months and then stop when symptoms seem to disappear. The treatment duration for pulmonary tuberculosis is considered to be at least six months, and for some patients, it may even extend to a year. However, not all cases of pulmonary tuberculosis can be completely cured. A small percentage of patients may not achieve complete eradication due to resistance to tuberculosis bacteria or intolerance to the side effects of tuberculosis medications. In such cases, the prognosis might be poor, and some individuals may succumb to tuberculosis due to these factors.
Local symptoms of pulmonary tuberculosis
The local symptoms of tuberculosis primarily require us to understand where tuberculosis occurs. Currently, tuberculosis in the lung tissues, trachea, bronchi, and pleura are all classified as pulmonary tuberculosis. The primary local symptoms are still respiratory symptoms, with the most common being cough and expectoration. Patients with tuberculosis generally have a slow onset, with most experiencing cough and expectoration that can persist for two weeks or more. Some patients may also exhibit symptoms like blood in the sputum or hemoptysis. Additionally, some patients may experience other symptoms; for example, those with pleural involvement might have irritative cough, chest pain, and difficulty breathing, while those with tracheobronchial involvement might exhibit a prolonged irritative cough. Some patients may also develop bronchial stenosis, which can lead to difficulty breathing.
Does tuberculosis cause a runny nose?
Do patients with tuberculosis have a runny nose? First, we need to understand what tuberculosis is. The pathogen of tuberculosis is Mycobacterium tuberculosis, commonly referred to as TB bacillus. Its primary site of infection is the lungs, but now we also classify and manage tracheobronchial and tuberculous pleurisy under pulmonary tuberculosis. However, these sites do not include the nasal part. Generally, patients with pulmonary tuberculosis show symptoms of the respiratory system and systemic symptoms. The most common respiratory symptoms include coughing and phlegm production for more than two weeks. Some patients may also experience hemoptysis, with varying amounts from mild to severe. A few patients may also experience chest pain. Additionally, patients with caseous pneumonia or significant pleural effusion may experience difficulty in breathing. Systemic symptoms of tuberculosis include fever, mainly characterized by afternoon tidal fever, with some patients exhibiting high fevers, and other general symptoms such as loss of appetite, weight loss, night sweats, and fatigue. However, the majority of patients with pulmonary tuberculosis do not exhibit nasal symptoms, meaning a runny nose is generally not a manifestation of tuberculosis. It could be possible that a tuberculosis patient might also have other infections or causative diseases, such as allergic rhinitis.
Can pneumonia vaccines prevent mycoplasma pneumonia?
Can pneumonia vaccines prevent Mycoplasma infections? First, we need to understand what pneumonia vaccines are. In our country, the most commonly used pneumonia vaccines are aimed at Streptococcus pneumoniae, which are divided into polysaccharide vaccines and conjugate vaccines. Polysaccharide vaccines are mainly suitable for individuals over two years old and include the 23-valent polysaccharide vaccine. This vaccine can prevent infections caused by twenty-three serotypes that often lead to S. pneumoniae infections, with over 90% of pneumonia caused by these twenty-three serotypes. However, the 23-valent polysaccharide vaccine does not prevent infections caused by other serotypes of S. pneumoniae. Additionally, the conjugate vaccine only prevents infections caused by either seven or thirteen serotypes. Since Mycoplasma is neither a bacterium nor a virus, it cannot be prevented by pneumonia vaccines, and currently, there is no vaccine available specifically for Mycoplasma infections.
Is respiratory failure contagious?
First, it's important to understand what respiratory failure is. Respiratory failure is a syndrome, not a disease, meaning it can result from many causes. For instance, airway obstruction, lung tissue pathology, diseases of the pulmonary vessels, and diseases of the thorax and pleura, as well as neuromuscular diseases, can all lead to impaired ventilation or gas exchange in the lungs. This impairment makes it impossible for the body to maintain adequate gas exchange even in a resting state, resulting in hypoxemia, with or without hypercapnia, which is referred to as respiratory failure. Therefore, there are many causes of respiratory failure, and some diseases are indeed contagious, such as SARS, H1N1, and H3N2. However, other causes, such as tumors or pulmonary embolism, are generally not contagious.
Does tuberculosis cause fever?
Does tuberculosis cause fever? The answer is definitely yes. Fever is one of the most common clinical manifestations of tuberculosis. Many tuberculosis patients experience low fevers, and a minority of patients, such as those with caseous tuberculosis or tuberculous pleurisy, may experience high fevers that can recur and persist. Moreover, tuberculosis patients may sometimes also have concurrent bacterial infections, which can cause the fever to last longer and be more difficult to control.